Phase 3 DREAM3R trial opens for malignant pleural mesothelioma

By | March 18, 2021
The DREAM3R phase three clinical trial is now enrolling patients with newly diagnosed unresectable malignant pleural mesothelioma (MPM) throughout the US, Australia, and New Zealand.